Madrigal Pharmaceuticals
MDGL
MDGL
124 hedge funds and large institutions have $1.38B invested in Madrigal Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 41 increasing their positions, 45 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 12
1% less funds holding
Funds holding: 125 → 124 (-1)
9% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 45
Holders
124
Holding in Top 10
3
Calls
$29.7M
Puts
$19.2M
Top Buyers
| 1 | +$64.1M | |
| 2 | +$22.3M | |
| 3 | +$20.6M | |
| 4 |
N
Natixis
Paris,
France
|
+$9.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$8.79M |
Top Sellers
| 1 | -$20.7M | |
| 2 | -$20.1M | |
| 3 | -$8.07M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.11M |
| 5 |
Renaissance Technologies
New York
|
-$6.01M |